US

Moderna stock

Moderna shares reverse big early gains in bout of profit-taking
Moderna (NASDAQ:MRNA) yesterday rose more than 20% on the news of positive results in its pivotal trial for Covid-19 vaccine candidate mRNA-1273.

Related News to Moderna stock